Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

Trial Phase 3 Completed Jan. 17, 2017

Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation

Trial N/A Completed Jan. 11, 2017

Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.

Trial Phase 1 Completed Jan. 5, 2017

Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension

Trial N/A Completed Jan. 5, 2017

A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions

Trial Phase 1 Completed Jan. 5, 2017

Lubiprostone as a Treatment for Constipation in Parkinson's Disease

Trial N/A Terminated Dec. 29, 2016

Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects

Trial Phase 1 Completed Dec. 15, 2016

ALTROPANE® SPECT Imaging in Patients With Parkinson Disease

Trial Phase 2 Completed Dec. 15, 2016

Goal-oriented Intervention in Parkinson's Disease

Trial N/A Completed Dec. 13, 2016

Understand FoG in PD: Behavioral Physiology and Clinical Application

Trial N/A Unknown Dec. 7, 2016

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

Trial Phase 1 Completed Dec. 4, 2016

Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm

Trial N/A Completed Dec. 4, 2016

Study of the Enteric Nervous System Using Colonic Biopsies in Parkinson Patients With LRRK2 Mutation

Trial N/A Terminated Nov. 30, 2016

Haptoglobin and Iron in Parkinson's Disease

Trial N/A Completed Nov. 28, 2016

Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol

Trial N/A Unknown Nov. 28, 2016

Effect of Body Suspension and Tilting Exercises in Parkinson's Disease

Trial N/A Completed Nov. 27, 2016

Benefit From the Chin Down Maneuver in the Swallowing Performance and Self-perception of Parkinson's Disease Patients

Trial N/A Completed Nov. 27, 2016

Exercise for Adults With Parkinson Disease

Trial N/A Unknown Nov. 21, 2016

Effects of Deep Brain Stimulation in Parkinson's Disease

Trial N/A Unknown Nov. 20, 2016

Concurrent DBS Local Field Potential Analysis and Stimulation in a Closed-Loop Neuromodulation Device

Trial N/A Withdrawn Nov. 16, 2016